- Home
- SNSE vs SVRN Comparison
SNSE vs SVRN Comparison
Compare SNSE & SVRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- SVRN
- Stock Information
- Founded
- SNSE 2005
- SVRN 2021
- Country
- SNSE United States
- SVRN Greece
- Employees
- SNSE N/A
- SVRN N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- SVRN Marine Transportation
- Sector
- SNSE Health Care
- SVRN Consumer Discretionary
- Exchange
- SNSE Nasdaq
- SVRN Nasdaq
- Market Cap
- SNSE 10.3M
- SVRN 9.1M
- IPO Year
- SNSE 2021
- SVRN N/A
- Fundamental
- Price
- SNSE $8.60
- SVRN $1.41
- Analyst Decision
- SNSE Strong Buy
- SVRN
- Analyst Count
- SNSE 5
- SVRN 0
- Target Price
- SNSE $72.50
- SVRN N/A
- AVG Volume (30 Days)
- SNSE 39.5K
- SVRN 153.3K
- Earning Date
- SNSE 11-14-2025
- SVRN 12-19-2025
- Dividend Yield
- SNSE N/A
- SVRN N/A
- EPS Growth
- SNSE N/A
- SVRN N/A
- EPS
- SNSE N/A
- SVRN N/A
- Revenue
- SNSE N/A
- SVRN $19,435,000.00
- Revenue This Year
- SNSE N/A
- SVRN N/A
- Revenue Next Year
- SNSE N/A
- SVRN N/A
- P/E Ratio
- SNSE N/A
- SVRN N/A
- Revenue Growth
- SNSE N/A
- SVRN N/A
- 52 Week Low
- SNSE $5.00
- SVRN $1.07
- 52 Week High
- SNSE $18.35
- SVRN $79.25
- Technical
- Relative Strength Index (RSI)
- SNSE 44.73
- SVRN N/A
- Support Level
- SNSE $8.37
- SVRN N/A
- Resistance Level
- SNSE $9.42
- SVRN N/A
- Average True Range (ATR)
- SNSE 1.08
- SVRN 0.00
- MACD
- SNSE -0.02
- SVRN 0.00
- Stochastic Oscillator
- SNSE 33.45
- SVRN 0.00
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).